Baxano Surgical Announces Closing Of $10 Million Private Placement Of Convertible Debentures

RALEIGH, N.C., April 23, 2014 (GLOBE NEWSWIRE) -- Baxano Surgical, Inc. (Nasdaq:BAXS) ("Baxano Surgical" or the "Company"), a medical device company focused on designing, developing and marketing minimally invasive products to treat degenerative conditions of the spine affecting the lumbar region, announced today the closing of its private placement of approximately $10 million aggregate principal amount of subordinated convertible debentures and warrants to purchase 9,428,000 shares of common stock to entities affiliated with two institutional investors.

Help employers find you! Check out all the jobs and post your resume.